KALV – Knox Daily

Stock Earnings

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. KalVista Pharmaceuticals

Insiders Updates

KalVista Pharmaceuticals Inc’s recent filing unveils that its CHIEF MEDICAL OFFICER Audhya Paul K. unloaded Company’s shares for reported $24272.0

Analysts Viewpoint

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

KalVista Pharmaceuticals Inc’s recent filing unveils that its 10% Owner Venrock Healthcare Capital Par acquired Company’s shares for reported $0.24

Analysts Viewpoint

KalVista Pharmaceuticals Inc’s recent filing unveils that its 10% Owner Venrock Healthcare Capital Par acquired Company’s shares for reported $0.24

Insiders Updates

KalVista Pharmaceuticals Inc’s recent filing unveils that its 10% Owner Venrock Healthcare Capital Par acquired Company’s shares for reported $0.24

Stock Earnings

KalVista Pharmaceuticals Inc’s recent filing unveils that its 10% Owner Venrock Healthcare Capital Par acquired Company’s shares for reported $0.24

Insiders Updates

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Tag: KALV